Recombinant subunit vaccines as an approach to study correlates of protection against primate lentivirus infection
- 30 June 1996
- journal article
- Published by Elsevier in Immunology Letters
- Vol. 51 (1-2) , 115-119
- https://doi.org/10.1016/0165-2478(96)02564-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Intrarectal inoculation of macaques by the simian immunodeficiency virus, SIVmne E11S: CD4 + depletion and AIDSJournal of Medical Primatology, 1994
- Measuring Vaccine-Induced HIV Neutralization: Report of a WorkshopAIDS Research and Human Retroviruses, 1994
- HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzeesVaccine, 1994
- Protection of vaccinia‐primed macaques against SIVmne infection by combination immunization with recombinant vaccinia virus and SIVmne gp160Journal of Medical Primatology, 1993
- Immune Responses to SIVmneEnvelope Glycoproteins Protect Macaques from Homologous SIV InfectionAIDS Research and Human Retroviruses, 1992
- Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibodyNature, 1992
- Protection of Macaques Against SIV Infection by Subunit Vaccines of SIV Envelope Glycoprotein gp160Science, 1992
- The Ability of Certain SIV Vaccines to Provoke Reactions Against Normal CellsScience, 1992
- Anti-cell antibody in macaquesNature, 1991
- Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160Nature, 1990